New At-Home Lab Testing Device Provides CBC Counts for Cancer Patients

I have been closely tracking the development of new at-home lab testing devices because I think, accompanied by expanded telemedicine choices, the face of healthcare will be changed forever. A recent article inDark Daily announced such a device for complete blood counts (CBC) (see:New At-Home CBC Device Enables Complete Blood Testing for Cancer Treatments and Biological/Viral Monitoring). Below is an excerpt from it:.....[N]ew devices that enable chronic disease patients to monitor and report findings to care providers continue to be developed and embraced by healthcare consumers. One such device fromAthelas, a diagnostic test developer based in Mountain View, Calif., makes it easier and less expensive for patients undergoing cancer therapy to monitor their complete blood counts (CBC) at home without the need to travel to a doctor or medical laboratory to have the blood work performed....The device, which is undergoing the FDA Class 2 clearance process, enables patients to test their complete blood count (CBC) in the privacy of their own homes and report the results to their oncologists....To use the Athelas device, patients perform a simple finger prick and place a drop of blood on a proprietary testing strip.The strip is then inserted into the device where the blood is analyzed. Patients can view their lab-grade blood test results in about a minute. Information gathered by the device can be sent to Android or iOS devices/apps and also to the patient ’s doctor....Acc...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Clinical Lab Industry News Clinical Lab Testing Cost of Healthcare Food and Drug Administration Healthcare Information Technology Lab Industry Trends Lab Processes and Procedures Medical Consumerism Point-of-Care Testing Test Kits and Ho Source Type: blogs